Skip to main content
logo
Genetic Signatures Limited (ASX:GSS)
Australia flag Australia · Delayed Price · Currency is AUD
0.1350
-0.0100 (-6.90%)
Feb 5, 2026, 11:24 AM AEST

Genetic Signatures Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Revenue
15.99.7716.9435.4228.28
Other Revenue
3.8544.570.080.1
Revenue
19.7513.7721.5135.528.38
Revenue Growth (YoY)
43.47%-36.00%-39.39%25.06%105.43%
Cost of Revenue
9.257.9111.8313.611.25
Gross Profit
10.515.869.6821.917.14
Selling, General & Admin
20.419.1119.4414.6712.19
Other Operating Expenses
2.343.093.312.581.99
Operating Expenses
25.1324.1924.2818.8715.61
Operating Income
-14.63-18.33-14.593.031.53
Interest Expense
-0.09-0.04-0-0.02-0.04
Interest & Investment Income
1.610.50.540.130.21
Currency Exchange Gain (Loss)
----0.09-0.07
Other Non Operating Income (Expenses)
---0.010.13
EBT Excluding Unusual Items
-13.11-17.86-14.053.061.76
Asset Writedown
-7----
Pretax Income
-20.1-17.86-14.053.061.76
Net Income
-20.1-17.86-14.053.061.76
Net Income to Common
-20.1-17.86-14.053.061.76
Net Income Growth
---74.43%-
Shares Outstanding (Basic)
227165143143143
Shares Outstanding (Diluted)
227165143145146
Shares Change (YoY)
37.18%15.25%-1.40%-0.16%14.76%
EPS (Basic)
-0.09-0.11-0.100.020.01
EPS (Diluted)
-0.09-0.11-0.100.020.01
EPS Growth
---74.39%-
Free Cash Flow
-12.94-12.1-14.388.09-0.46
Free Cash Flow Per Share
-0.06-0.07-0.100.06-0.00
Gross Margin
53.19%42.53%45.01%61.69%60.38%
Operating Margin
-74.06%-133.14%-67.83%8.54%5.38%
Profit Margin
-101.78%-129.74%-65.32%8.63%6.19%
Free Cash Flow Margin
-65.52%-87.88%-66.86%22.80%-1.61%
EBITDA
-12.67-16.53-13.074.32.56
EBITDA Margin
-64.14%-120.05%-60.74%12.12%9.02%
D&A For EBITDA
1.961.81.531.271.03
EBIT
-14.63-18.33-14.593.031.53
EBIT Margin
-74.05%-133.14%-67.83%8.54%5.38%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.